TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
MedAdvisor Limited ( (AU:MDR) ) has issued an update.
MedAdvisor Limited has announced the application for quotation of 2,000,000 fully paid ordinary securities on the Australian Securities Exchange (ASX). This move is part of previously announced transactions and is expected to enhance the company’s financial flexibility, potentially impacting its market positioning and offering new opportunities for stakeholders.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare technology industry, providing digital solutions to enhance medication management. The company focuses on developing platforms that connect patients with healthcare professionals to streamline prescription management and improve patient adherence to medication regimens.
Average Trading Volume: 1,456,339
Technical Sentiment Signal: Sell
Current Market Cap: A$12.69M
For an in-depth examination of MDR stock, go to TipRanks’ Overview page.